Healthcare Industry News: Parkinson's disease
News Release - February 24, 2021
SpinTech Acquires MR InnovationsBINGHAM FARMS, Mich., Feb. 24, 2021 -- (Healthcare Sales & Marketing Network) -- Detroit-based MRI technology company SpinTech, Inc. has acquired medical-imaging research and technology developer Magnetic Resonance Innovations, Inc. (MR Innovations). The acquisition brings an expert team of PhD and master's-level engineers and physicists and also includes MR Innovations' 10 patents, over 300 published papers and a network of more than 50 global collaborators.
To honor the legacy of MR Innovations, the company, which currently does business under the name SpinTech Imaging, will rebrand to use the name SpinTech MRI.
"Our goal has always been to push the boundaries of what's possible with MRI while delivering practical solutions for the benefit of clinicians and patients along the way," said company CEO Ward Detwiler. "With the acquisition of MR Innovations, we're able to better pioneer the forefront of MRI technology while continually improving the present."
Joining SpinTech to provide fully-integrated research and development, MR Innovations also brings its expertise in protocol development for medical imaging scans, image processing services, clinical research organization consulting, and innovation in imaging hardware and software. "We are thrilled to provide end-to-end technology development for our MRI partners, radiologists, neurologists and researchers through this acquisition," said Detwiler.
In the past, MR Innovations and SpinTech have worked closely to create innovative technology for products such as STAGE, a standardized MRI software program allowing for improved efficiency and AI-assisted detection. STAGE technology allows for up to 40% faster MRI acquisition times for brain scans, improved visualization, and quantitative results with applications across conditions such as Parkinson's disease, dementia, traumatic brain injury, multiple sclerosis and stroke.
"With the expertise of our MR Innovations team members," said Founder and Chief Science Officer, Dr. E. Mark Haacke, PhD, "SpinTech MRI will now see medical imaging software production from base research to clinical deployment, continuing to lead MRI technology development with revolutionary ideas realized through fully supported software and products."
SpinTech produces rapid, quantitative brain imaging software which assists clinicians and researchers in the quick acquisition and interpretation of MRI results. Through enhanced early detection and quantification of biomarkers critical to many neurological disorders, SpinTech technology aids in improving patient outcomes and efficiency, all while reducing costs.
Learn more about SpinTech at https://spintechimaging.com
Issuer of this News Release is solely responsible for its
Please address inquiries directly to the issuing company.